GO
Loading...

This Pharma Company Could Be Flying Again

Wednesday, 26 Oct 2011 | 6:52 PM ET
Will Allergan Raise It's Guidance?
David Pyott, Allergan chairman/CEO, discusses the company's earnings, and products in the big pharma pipeline, with Mad Money's Jim Cramer.

Allergan is the fastest growing pharma company around, and Cramer sees a ton of catalysts moving forward, the ”Mad Money” host said Thursday.

“I like Allergan not just because it knows how to make people look good,” he said, “but because it knows how to make its business grow in a way that's both smart and sustainable.”

The company reported a terrific quarter Thursday morning, posting a 2 cent earnings beat off a 90 cent basis and in-line revenues. It also raised full-year guidance.

Despite those numbers, the stock got slammed. That’s because when you are the fastest growing pharmaceutical, you need to deliver a “flawless” quarter and raise guidance a lot, Cramer said.

But thanks to his robust pipeline, he thinks the stock could be flying again in no time.

To dig deeper into the company’s prospects, Cramer spoke with CEO David Pyott. Watch the video to see the full interview.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
AEF
---

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.